193 related articles for article (PubMed ID: 36469421)
21. Synthesis and Biological Evaluation of Novel Heterocyclic Imines Linked Coumarin- Thiazole Hybrids as Anticancer Agents.
Goud NS; Ghouse MS; Vishnu J; Pranay J; Alvala R; Talla V; Qureshi IA; Alvala M
Anticancer Agents Med Chem; 2019; 19(4):557-566. PubMed ID: 30734685
[TBL] [Abstract][Full Text] [Related]
22. Design, synthesis, in vitro and in silico studies of some novel thiazole-dihydrofuran derivatives as aromatase inhibitors.
Osmaniye D; Görgülü Ş; Sağlık BN; Levent S; Özkay Y; Kaplancıklı ZA
Bioorg Chem; 2021 Sep; 114():105123. PubMed ID: 34214753
[TBL] [Abstract][Full Text] [Related]
23. Design, Synthesis, and Molecular Docking of Paracyclophanyl-Thiazole Hybrids as Novel CDK1 Inhibitors and Apoptosis Inducing Anti-Melanoma Agents.
Aly AA; Bräse S; Hassan AA; Mohamed NK; El-Haleem LEA; Nieger M; Morsy NM; Alshammari MB; Ibrahim MAA; Abdelhafez EMN
Molecules; 2020 Nov; 25(23):. PubMed ID: 33260954
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and evaluation of bis-thiazole derivatives as new anticancer agents.
Turan-Zitouni G; Altıntop MD; Özdemir A; Kaplancıklı ZA; Çiftçi GA; Temel HE
Eur J Med Chem; 2016 Jan; 107():288-94. PubMed ID: 26599534
[TBL] [Abstract][Full Text] [Related]
25. New thiazole-2(3H)-thiones containing 4-(3,4,5-trimethoxyphenyl) moiety as anticancer agents.
Ansari M; Shokrzadeh M; Karima S; Rajaei S; Fallah M; Ghassemi-Barghi N; Ghasemian M; Emami S
Eur J Med Chem; 2020 Jan; 185():111784. PubMed ID: 31669850
[TBL] [Abstract][Full Text] [Related]
26. 2-(2-Hydrazinyl)thiazole derivatives: design, synthesis and in vitro antimycobacterial studies.
Makam P; Kankanala R; Prakash A; Kannan T
Eur J Med Chem; 2013 Nov; 69():564-76. PubMed ID: 24095750
[TBL] [Abstract][Full Text] [Related]
27. Design, synthesis, molecular docking, in silico ADMET profile and anticancer evaluations of sulfonamide endowed with hydrazone-coupled derivatives as VEGFR-2 inhibitors.
Sayed AM; Taher FA; Abdel-Samad MRK; El-Gaby MSA; El-Adl K; Saleh NM
Bioorg Chem; 2021 Mar; 108():104669. PubMed ID: 33515863
[TBL] [Abstract][Full Text] [Related]
28. Design, synthesis and biological evaluation of some new 1,3,4-thiadiazine-thiourea derivatives as potential antitumor agents against non-small cell lung cancer cells.
Ragab FAF; Abdel-Aziz SA; Kamel M; Ouf AMA; Allam HA
Bioorg Chem; 2019 Dec; 93():103323. PubMed ID: 31586713
[TBL] [Abstract][Full Text] [Related]
29. New chromanone derivatives containing thiazoles: Synthesis and antitumor activity evaluation on A549 lung cancer cell line.
Yurttaş L; Temel HE; Aksoy MO; Bülbül EF; Çiftçi GA
Drug Dev Res; 2022 Apr; 83(2):470-484. PubMed ID: 34532880
[TBL] [Abstract][Full Text] [Related]
30. New thiazol-hydrazono-coumarin hybrids targeting human cervical cancer cells: Synthesis, CDK2 inhibition, QSAR and molecular docking studies.
Abd El-Karim SS; Syam YM; El Kerdawy AM; Abdelghany TM
Bioorg Chem; 2019 May; 86():80-96. PubMed ID: 30685646
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and biological evaluation of purine-pyrazole hybrids incorporating thiazole, thiazolidinone or rhodanine moiety as 15-LOX inhibitors endowed with anticancer and antioxidant potential.
Afifi OS; Shaaban OG; Abd El Razik HA; Shams El-Dine SEA; Ashour FA; El-Tombary AA; Abu-Serie MM
Bioorg Chem; 2019 Jun; 87():821-837. PubMed ID: 30999135
[TBL] [Abstract][Full Text] [Related]
32. Novel benzotriazole N-acylarylhydrazone hybrids: Design, synthesis, anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis and FAK inhibition.
Kassab AE; Hassan RA
Bioorg Chem; 2018 Oct; 80():531-544. PubMed ID: 30014921
[TBL] [Abstract][Full Text] [Related]
33. New chalcone-tethered 1,3,5-triazines potentiate the anticancer effect of cisplatin against human lung adenocarcinoma A549 cells by enhancing DNA damage and cell apoptosis.
El-Wakil MH; Khattab SN; El-Yazbi AF; El-Nikhely N; Soffar A; Khalil HH
Bioorg Chem; 2020 Dec; 105():104393. PubMed ID: 33120322
[TBL] [Abstract][Full Text] [Related]
34. Cytotoxic and Apoptotic Effects of Novel Pyrrolo[2,3-d]Pyrimidine Derivatives Containing Urea Moieties on Cancer Cell Lines.
Kilic-Kurt Z; Bakar-Ates F; Karakas B; Kütük Ö
Anticancer Agents Med Chem; 2018; 18(9):1303-1312. PubMed ID: 29866023
[TBL] [Abstract][Full Text] [Related]
35. Synthesis of thiazole linked indolyl-3-glyoxylamide derivatives as tubulin polymerization inhibitors.
Guggilapu SD; Guntuku L; Reddy TS; Nagarsenkar A; Sigalapalli DK; Naidu VGM; Bhargava SK; Bathini NB
Eur J Med Chem; 2017 Sep; 138():83-95. PubMed ID: 28648953
[TBL] [Abstract][Full Text] [Related]
36. Novel triazolophthalazine-hydrazone hybrids as potential PCAF inhibitors: Design, synthesis, in vitro anticancer evaluation, apoptosis, and molecular docking studies.
Abulkhair HS; Turky A; Ghiaty A; Ahmed HEA; Bayoumi AH
Bioorg Chem; 2020 Jul; 100():103899. PubMed ID: 32454390
[TBL] [Abstract][Full Text] [Related]
37. Development of Thiazole-5-carboxylate Derivatives as Selective Inhibitors of Monoacylglycerol Lipase as Target in Cancer.
Ali MR; Kumar S; Shalmali N; Afzal O; Azim S; Chanana D; Alam O; Paudel YN; Sharma M; Bawa S
Mini Rev Med Chem; 2019; 19(5):410-423. PubMed ID: 29962341
[TBL] [Abstract][Full Text] [Related]
38. Synthesis, density functional theory calculation, molecular docking studies, and evaluation of novel 5-nitrothiophene derivatives for anticancer activity.
Nuha D; Evren AE; Çiyanci ZŞ; Temel HE; Akalin Çiftçi G; Yurttaş L
Arch Pharm (Weinheim); 2022 Sep; 355(9):e2200105. PubMed ID: 35584987
[TBL] [Abstract][Full Text] [Related]
39. Novel 2-indolinone thiazole hybrids as sunitinib analogues: Design, synthesis, and potent VEGFR-2 inhibition with potential anti-renal cancer activity.
Mahmoud HK; Farghaly TA; Abdulwahab HG; Al-Qurashi NT; Shaaban MR
Eur J Med Chem; 2020 Dec; 208():112752. PubMed ID: 32947227
[TBL] [Abstract][Full Text] [Related]
40. Amino Acid Conjugates of Aminothiazole and Aminopyridine as Potential Anticancer Agents: Synthesis, Molecular Docking and in vitro Evaluation.
Naz S; Shah FA; Nadeem H; Sarwar S; Tan Z; Imran M; Ali T; Li JB; Li S
Drug Des Devel Ther; 2021; 15():1459-1476. PubMed ID: 33833504
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]